Renovis Enters Worldwide Collaboration, License Agreement With Pfizer

Renovis, Inc., a developer of drugs to treat neurological diseases and disorders, announced that it has entered into a worldwide collaboration and licensing agreement with Pfizer Inc. to research, develop and commercialize small molecules that target the vanilloid receptor, VR1. The collaboration will focus on treatments for pain, urinary incontinence, and other diseases and disorders.

()a href="http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-31-2005/0003766485&EDATE=" target="_blank">PR Newswire